Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Ossium Health, Inc.
Essen Biotech
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
ARCE Therapeutics, Inc.
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Instituto Nacional de Cancer, Brazil
Hoffmann-La Roche
Columbia University
Indiana University
M.D. Anderson Cancer Center
Washington University School of Medicine
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sanofi
University of Kentucky
Fred Hutchinson Cancer Center